| Trends in primary liver cancer S Deuffic, T Poynard, L Buffat, AJ Valleron The Lancet 351 (9097), 214-215, 1998 | 378 | 1998 |
| Modeling the hepatitis C virus epidemic in France S Deuffic, L Buffat, T Poynard, AJ Valleron Hepatology 29 (5), 1596-1601, 1999 | 263 | 1999 |
| Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study Y Yazdanpanah, G De Carli, B Migueres, F Lot, M Campins, C Colombo, ... Clinical Infectious Diseases 41 (10), 1423-1430, 2005 | 217 | 2005 |
| Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States S Deuffic‐Burban, T Poynard, MS Sulkowski, JB Wong Journal of viral hepatitis 14 (2), 107-115, 2007 | 185 | 2007 |
| Predicted effects of treatment for HCV infection vary among European countries S Deuffic–Burban, P Deltenre, M Buti, T Stroffolini, J Parkes, ... Gastroenterology 143 (4), 974-985. e14, 2012 | 134 | 2012 |
| Routine HIV screening in France: clinical impact and cost-effectiveness Y Yazdanpanah, CE Sloan, C Charlois-Ou, S Le Vu, C Semaille, ... PloS one 5 (10), e13132, 2010 | 130 | 2010 |
| Blood-borne viruses in health care workers: prevention and management S Deuffic-Burban, E Delarocque-Astagneau, D Abiteboul, E Bouvet, ... Journal of Clinical Virology 52 (1), 4-10, 2011 | 124 | 2011 |
| Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections S Deuffic-Burban, MK Mohamed, B Larouze, F Carrat, AJ Valleron Journal of hepatology 44 (3), 455-461, 2006 | 108 | 2006 |
| Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire A Pasquet, E Messou, D Gabillard, A Minga, A Depoulosky, ... PloS one 5 (10), e13414, 2010 | 106 | 2010 |
| Hepatitis C virus treatment in the real world: optimising treatment and access to therapies F Zoulim, TJ Liang, AL Gerbes, A Aghemo, S Deuffic-Burban, G Dusheiko, ... Gut 64 (11), 1824-1833, 2015 | 101 | 2015 |
| Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study K Champenois, A Cousien, L Cuzin, S Le Vu, S Deuffic-Burban, E Lanoy, ... BMC infectious diseases 13 (1), 200, 2013 | 89 | 2013 |
| Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe S Deuffic, T Poynard, AJ Valleron Journal of viral hepatitis 6 (5), 411-413, 1999 | 89 | 1999 |
| Adjuvant intraperitoneal 5-fluorouracil in high-risk colon cancer: a multicenter phase III trial JC Vaillant, B Nordlinger, S Deuffic, JP Arnaud, E Pelissier, JP Favre, ... Annals of surgery 231 (4), 449, 2000 | 88 | 2000 |
| Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness L Bocket, A Cheret, S Deuffic-Burban, P Choisy, Y Gerard, ... Antivir Ther 10 (2), 247-54, 2005 | 83 | 2005 |
| Comparing the public health burden of chronic hepatitis C and HIV infection in France S Deuffic-Burban, JB Wong, AJ Valleron, D Costagliola, JF Delfraissy, ... Journal of hepatology 40 (2), 319-326, 2004 | 73 | 2004 |
| Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model S Deuffic‐Burban, T Poynard, AJ Valleron Journal of viral hepatitis 9 (2), 114-122, 2002 | 73 | 2002 |
| The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference A Hatzakis, P Van Damme, K Alcorn, C Gore, M Benazzouz, S Berkane, ... Journal of viral hepatitis 20, 1-20, 2013 | 70 | 2013 |
| Hepatitis C treatment as prevention of viral transmission and liver‐related morbidity in persons who inject drugs A Cousien, VC Tran, S Deuffic‐Burban, M Jauffret‐Roustide, JS Dhersin, ... Hepatology 63 (4), 1090-1101, 2016 | 67 | 2016 |
| Impact of viral eradication on mortality related to hepatitis C: a modeling approach in France S Deuffic-Burban, P Deltenre, A Louvet, V Canva, S Dharancy, ... Journal of hepatology 49 (2), 175-183, 2008 | 67 | 2008 |
| Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141) S Deuffic-Burban, M Schwarzinger, D Obach, V Mallet, S Pol, ... Journal of hepatology 61 (1), 7-14, 2014 | 65 | 2014 |
